openPR Logo
Press release

Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up of the management board at Medos

08-10-2011 08:29 AM CET | Health & Medicine

Press release from: Medos Medizintechnik

Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up

Medos AG is preparing for the step up to becoming a complete provider in the area of cardiac surgery by recruiting the former Maquet managers Dr. Jürgen Böhm und Josef Bogenschütz.

On the 1st August, heart surgeon Dr. Jürgen Böhm and graduate engineer Josef Bogenschütz became members of the management board at Medos Medizintechnik AG and, in so doing, completed the line-up. As a result, there will be a clear focus on the continuous development of a predetermined product range for cardiac surgery and cardiovascular technology. Dr. Böhm is responsible for clinical management, marketing, new business developments and certification and Mr. Bogenschütz for sales, research and development, production and quality management. Dr. Volker Hamm, spokesperson of the management board, is, as before, responsible for the areas of finance, human resources, IT and purchasing.

"I am very much looking forward to working with Mr. Bogenschütz and Dr. Böhm", said Dr. Hamm. "Along with their proven leadership qualities, both have considerable expertise in the development and marketing of products and services pertaining to cardiac surgery. As a result, we are ideally placed to develop our status as an innovative and continually stable partner for heart surgeons and cardiovascular engineers.”

"Medos has the potential to develop into a gem of a technology company, with a stable future in cardiac surgery applications as well as other peripheral markets“, according to Dr. Böhm. "I am particularly looking forward to having close personal contact with our customers, in order to address their wishes and to instigate the development of successively improved and novel approaches to creating innovative therapy solutions." Mr. Bogenschütz makes it clear that Medos will invest heavily when it comes to expanding the product range and "will continue to concentrate on top quality products - made in Germany. Our aim is to expand our position as complete provider in the area of cardiac surgery."

Thomas Villinger, managing director of the German company Zukunftsfonds Heilbronn, or zfhn for short, (full owner of Medos since the beginning of 2011) emphasises that the objective is "to establish Medos as a healthy, German, fast-growing, midsize company specialising in medical devices. With the new board members, Mr. Bogenschütz and Dr. Böhm, we are providing Medos with a powerful engine to help achieve this objective."

Dr. Böhm can draw on four years' experience working as clinical director at Maquet Cardiopulmonary AG in Hirrlingen, Germany and likewise at Maquet Cardiovascular in Wayne, USA. The 44-year old doctor was active for many years at Sana Herzchirurgischen Klinik (Sana heart surgery clinic) in Stuttgart. The heart surgeon, who acquired a teaching qualification at Eberhard-Karls-Universität in Tübingen, Germany, switched to the medical devices sector four years ago.
Mr. Bogenschütz was most recently the chairman of the management board at Maquet Cardiopulmonary AG. The 45-year old engineer began his career in the manufacturing sector, working at Bizerba GmbH and Beru AG, before switching to the medical devices sector eleven years ago, when he joined Jostra AG.

Background information

Medos AG
Medos AG is a leading, midsize, high-tech, German company specialising in medical devices, that develops, manufactures and globally markets products used for cardiac surgery as well as peripheral applications. From the very beginning, Medos has focussed on the quality of development and production, adopting a "Made in Germany" approach. Consequently, the complete range of products for cardiac surgery operations is manufactured using high technology at the German production facilities in Stolberg and Radeberg, products which have already been used for thousands of patients.

The product range fundamentally comprises Medos tube sets and also includes in-house developments such as HILITE® oygenators and reservoirs, RHEOPARIN® coatings (heparin), the DELTASTREAM® series, Medos VAD system products with various ventricles and cannulae, and a comprehensive set of Medos cannulae.

Zukunftsfonds Heilbronn
The German equity firm Zukunftsfonds Heilbronn (zfhn), formed in 2006, assists early-stage, technology-based companies in North Würtemberg, from the start-up stage, where innovative ideas are developed, through to successful establishment. It concentrates on sunrise sectors such as life sciences, IT and energy, industrial and environmental technologies. The companies receive long-term support from zfhn and become established in the economic region of Heilbronn. Alongside the high business expertise of its managers and administrators, the main strength of the equity firm is its excellent regional and international business connections.

Judith Reiners
Head of Marketing
Obere Steinfurt 8-10
52222 Stolberg
Germany
j.reiners@medos-ag.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Jürgen Böhm and Josef Bogenschütz complete the line-up of the management board at Medos here

News-ID: 186959 • Views: 3094

More Releases from Medos Medizintechnik

Medos Medizintechnik AG inaugurates new site
Management Board members Dr. Böhm and Mr. Bogenschütz officially inaugurated a new development site in Germany. The inauguration of the new Medos site is a further step forwards in the company's consistent implementation of its defined strategy of creating new technologies and therapeutic concepts. Medos develops, manufactures and markets products and therapies in the field of cardiac surgery for the treatment of heart attacks. The new development department in Reutlingen, Germany, will
Medos Medizintechnik AG gets a visual makeover
The changes that came with the company's newly-defined strategic focus are now clearly visible for the world to see. Medos presented its complete design makeover for the first time at the 25th Annual European Congress of Cardiac and Thoracic Surgeons (EACTS) in Lisbon in early October. The redesign is a logical consequence after the company’s repositioning. "We want Medos’ new, clear strategy to be reflected in our corporate design,"

More Releases for Böhm

01-22-2019 | Health & Medicine
Fact.MR
Phototherapy Devices Market Scenario Indicates Prime Trends & Growth Parameters, …
Phototherapy devices are used for treating neonatal jaundice and various skin conditions. These devices are extensively used in procedures such as reducing of bilirubin serum concentration or curing bilirubin toxicity.   As per the latest report published by Fact.MR, the global phototherapy devices market will expand at 4.7% CAGR over the forecast period (2017-2022) . On the basis of in depth analysis the market is segmented by Product types, By End User, By Light
Phototherapy Lamps Market anticipated to grow By Product Type, End User and Appl …
Crystal Market Research Announced the Latest Addition “Phototherapy Lamps Market” Report Which Includes Detailed Study of Market Landscape and Important Projections For The Market. This Report Establishes Deep Estimation of Global Market Including Accepted Technologies and Trending Market Values Request For Sample Copy @ https://www.crystalmarketresearch.com/report-sample/HC06935 Major Top Key Insights: Drägerwerk, TSE spol. s.r.o, General Electric, Philips, Schulze & Böhm GmbH, Natus Medical Incorporated, Waldmann - Engineer of Light – H, Waldmann GmbH & Co.
Phototherapy Lamps Market driving most advantageous growth | By Application, End …
An ongoing report assessed a decisive investigation added by Crystal Market Research on Phototherapy Lamps Market report presents an all-inclusive study of the market by analyzing the key development trends, driving forces and restraints. This report offers a profound estimation of the including acknowledged innovations, market standardization future rules and esteem chain. To get holistic SAMPLE of the report @ https://www.crystalmarketresearch.com/report-sample/HC06935 Competitive Insights The leading players in the market are Drägerwerk, TSE spol. s.r.o,
Phototherapy Lamps Market Report Focuses Major Eminent Players like Drägerwerk, …
The Phototherapy Lamps Market research report provided by Crystal Market Research (CMR) is the most detailed study about Phototherapy Lamps that is estimated to grow at a tremendous rate over the forecast period 2018-2023. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Top Most Players: The leading players in the market are Drägerwerk, TSE spol. s.r.o, General Electric, Philips, Schulze
Donauer Solartechnik Completes Photovoltaic Plants in South Africa
Directly following Intersolar Europe 2012, Donauer Solartechnik will commission a photovoltaic plant on the roof of the University of the Witwatersrand in the South African city of Johannesburg. The plant will deliver an annual yield of around 2,800 kilowatt hours and is a part of a project to provide environmentally friendly electricity for two educational institutions on location. In cooperation with a German project developer and a South African installation
Bühler Motor reinforces its R&D division
Dr. Ralph Böhm is the new Bühler Motor Vice President Research and Development Since the beginning of October, Bühler Motor’s R&D division is the responsibility of the very experienced Dr. Ralph Böhm. As Vice President Research and Development he is responsible and a focal point for the Bühler Motor Group development activities worldwide. Previously, Dr. Ralph Böhm (46) was head of the Friedrichshafen-based automotive supplier ZF’s electromechanics, electrohydraulics and sensor technology